BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16995447)

  • 1. Effect of percutaneous biliary drainage on serum levels of tumor markers in patients with obstructive jaundice.
    Koroglu M; Koroglu BK; Akhan O; Coskun HS; Yildizz H; Yesildag A; Oyar O
    Hepatogastroenterology; 2006; 53(70):491-6. PubMed ID: 16995447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of percutaneous transhepatic biliary drainage on renal function in patients with obstructive jaundice.
    Parıldar Z; Çınar C; Barutçuoğlu B; Başol G; Parıldar M
    Diagn Interv Radiol; 2011 Mar; 17(1):74-9. PubMed ID: 20690079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
    Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
    Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancers.
    Kasuga A; Ishii H; Ozaka M; Matsusaka S; Chin K; Mizunuma N; Yukisawa S; Matsueda K; Furuse J
    Jpn J Clin Oncol; 2012 Dec; 42(12):1161-7. PubMed ID: 23072841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-biliary contrast-enhanced ultrasound for evaluating biliary obstruction during percutaneous transhepatic biliary drainage: a preliminary study.
    Xu EJ; Zheng RQ; Su ZZ; Li K; Ren J; Guo HY
    Eur J Radiol; 2012 Dec; 81(12):3846-50. PubMed ID: 22835875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease.
    Kim MS; Jeon TJ; Park JY; Choi J; Shin WC; Park SE; Seo JY; Kim YM
    Korean J Gastroenterol; 2017 Aug; 70(2):96-102. PubMed ID: 28830135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of serum neopterin in obstructive jaundice secondary to malignant lesions treated by percutaneous transhepatic biliary drainage.
    Yilmaz B; Parildar Z; Bozkaya H; Barutcuoglu B; Cinar C; Basol G; Parildar M; Ozmen D
    J Vasc Interv Radiol; 2013 Jun; 24(6):865-72. PubMed ID: 23707094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional helical computed tomography cholangiography with minimum intensity projection in gallbladder carcinoma patients with obstructive jaundice: comparison with magnetic resonance cholangiography and percutaneous transhepatic cholangiography.
    Rao ND; Gulati MS; Paul SB; Pande GK; Sahni P; Chattopadhyay TK
    J Gastroenterol Hepatol; 2005 Feb; 20(2):304-8. PubMed ID: 15683436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic change of serum CA19-9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas.
    Zhao B; Cheng Q; Cao H; Zhou X; Li T; Dong L; Wang W
    BMC Cancer; 2021 May; 21(1):517. PubMed ID: 33962560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
    Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice].
    Bai AG; Zheng CS; Zhou GF; Liang HM; Feng GS
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):456-8. PubMed ID: 20819490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilirubin levels predict malignancy in patients with obstructive jaundice.
    Garcea G; Ngu W; Neal CP; Dennison AR; Berry DP
    HPB (Oxford); 2011 Jun; 13(6):426-30. PubMed ID: 21609376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feasibility and usefulness of CT fluoroscopy-guided percutaneous transhepatic biliary drainage in emergency patients with acute obstructive cholangitis.
    Kim JH
    Korean J Radiol; 2009; 10(2):144-9. PubMed ID: 19270860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study.
    Kubo K; Kawakami H; Kuwatani M; Nishida M; Kawakubo K; Kawahata S; Taya Y; Kubota Y; Amano T; Shirato H; Sakamoto N
    BMC Gastroenterol; 2016 Jul; 16(1):65. PubMed ID: 27391646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
    Ng WW; Tong KJ; Tam TN; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUS-guided transduodenal biliary drainage in unresectable pancreatic cancer with obstructive jaundice.
    Ang TL; Teo EK; Fock KM
    JOP; 2007 Jul; 8(4):438-43. PubMed ID: 17625296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Study on Using
    Wang T; Liu S; Zheng YB; Song XP; Sun BL; Jiang WJ; Wang LG
    Anticancer Res; 2017 Aug; 37(8):4649-4653. PubMed ID: 28739766
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term outcome of interventional therapy for malignant biliary obstruction: a retrospective analysis of 109 cases].
    Li MQ; Zhang JX; Lu CH; Pan H; Ru FM; Cao CW; Xu JC; Xu JH
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2743-7. PubMed ID: 19080446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilothorax as a complication of percutaneous transhepatic biliary drainage.
    Sano A; Yotsumoto T
    Asian Cardiovasc Thorac Ann; 2016 Jan; 24(1):101-3. PubMed ID: 26294694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.